|
Mar 18
|
Guardant posts data for colon cancer blood test amid push from rivals
|
|
Mar 13
|
Cathie Wood Darling Exact Sciences Rises On Highly Anticipated Colon Cancer News
|
|
Mar 13
|
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
|
|
Mar 11
|
The Zacks Analyst Blog Highlights Legend Biotech, Exact Sciences, Exelixis, Ascendis Pharma and MorphoSys
|
|
Mar 11
|
2 Beaten-Down Cathie Wood Stocks With Massive Potential
|
|
Mar 8
|
Can Exact Sciences (EXAS) Climb 55.43% to Reach the Level Wall Street Analysts Expect?
|
|
Mar 8
|
5 Biotechnology Stocks to Buy for a Stable Portfolio in 2024
|
|
Mar 7
|
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
|
|
Mar 5
|
Exact Sciences Corp (EXAS) Director Daniel Levangie Sells 5,000 Shares
|
|
Mar 4
|
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
|
|
Mar 4
|
7 Stable Stocks to Buy for 100% Returns by 2025
|
|
Feb 10
|
Top 11 CRISPR Stocks To Invest In
|
|
Feb 7
|
Cathie Wood Is Selling This Stock: Should You?
|
|
Jan 13
|
BIIB, ZTS, EXAS: Which “Strong Buy” Healthcare Stock is Best?
|
|
Jan 3
|
Moderna (MRNA) Moves 13.1% Higher: Will This Strength Last?
|
|
Jan 2
|
Exact Sciences to participate in J.P. Morgan Healthcare Conference
|
|
Dec 21
|
Exact Sciences' (EXAS) Solid Cologuard Sales, Innovation Aid
|
|
Dec 17
|
1 Supercharged Growth Stock to Buy Before It Soars as Much as 222%, According to Cathie Wood's Ark Invest
|
|
Dec 14
|
Ark Invest Stock Portfolio: 16 Biggest Positions
|
|
Dec 13
|
Better Growth Stock: Vertex Pharmaceuticals or Exact Sciences?
|